|
(BASF) -- BASF announced today that it is
concentrating its plant biotechnology activities on the main markets in North
and South America. The company will adjust the portfolio and site footprint of
its subsidiary BASF Plant Science to reflect this
change.
|
 |
The headquarters of BASF Plant Science will be moved from Limburgerhof,
Germany, to Raleigh, North Carolina. Research and development activities will be
concentrated mainly in Raleigh, Ghent, Belgium and Berlin, Germany. Development
and commercialization of all products targeted solely at cultivation in the
European market will be halted. Regulatory approval processes which have already
started will be continued.
|
|
“We are convinced that plant biotechnology is a key technology for the
21st century. However, there is still a lack of acceptance for this technology
in many parts of Europe - from the majority of consumers, farmers and
politicians. Therefore, it does not make business sense to continue investing in
products exclusively for cultivation in this market,” said Dr. Stefan
Marcinowski, member of the Board of Executive Directors of BASF, responsible for
plant biotechnology.
mrcplast.com
| |
